2022 -- S 2197 | |
======== | |
LC003915 | |
======== | |
STATE OF RHODE ISLAND | |
IN GENERAL ASSEMBLY | |
JANUARY SESSION, A.D. 2022 | |
____________ | |
A N A C T | |
RELATING TO HEALTH AND SAFETY -- THE RHODE ISLAND RARE DISEASE | |
MEDICATION ACCESSIBILITY, AFFORDABILITY AND REINSURANCE ACT | |
| |
Introduced By: Senators DiPalma, and Miller | |
Date Introduced: February 08, 2022 | |
Referred To: Senate Health & Human Services | |
It is enacted by the General Assembly as follows: | |
1 | SECTION 1. Legislative findings and purpose. |
2 | (1) Advancements in medical research is leading to medications which give new hope to |
3 | cure otherwise fatal or debilitating rare diseases. The state recognizes these medications have |
4 | exceedingly high and immediate costs. Due to the rareness of the conditions, the drug treatment |
5 | costs are not well distributed across the health care financing system. These high cost and rare |
6 | treatments trigger financial complications for an employer, municipality, the Medicaid program, |
7 | the state as an employer, and health insurers, in a way that treatments for common conditions do |
8 | not; some employers and programs may even consider excluding coverage. Therefore, it is in the |
9 | interest of the state to facilitate coverage and fair financing by allocating the costs incurred for |
10 | covering such medications as broadly as possible. |
11 | (2) This chapter establishes within the executive office of health and human services a |
12 | program, informed by an advisory council, to assure equitable financing and thereby to facilitate |
13 | access to life changing medication for rare diseases. |
14 | SECTION 2. Title 23 of the General Laws entitled "HEALTH AND SAFETY" is hereby |
15 | amended by adding thereto the following chapter: |
16 | CHAPTER 97 |
17 | THE RHODE ISLAND RARE DISEASE MEDICATION ACCESSIBILITY, |
18 | AFFORDABILITY AND REINSURANCE ACT |
| |
1 | 23-97-1. Short title. |
2 | This chapter shall be known and may be cited as the "The Rhode Island Rare Disease |
3 | Medication Accessibility, Affordability and Reinsurance Act". |
4 | 23-97-2. Definitions. |
5 | The following words and phrases as used in this chapter shall have the following meaning: |
6 | (1)(i) "Contribution enrollee" means an individual residing in this state, with respect to |
7 | whom an insurer administers, provides, pays for, insures, or covers health care services, unless |
8 | excepted by this section. |
9 | (ii) It also means an individual residing outside this state, when covered by a contract, |
10 | policy, or plan that is delivered, issued for delivery, or renewed in this state. |
11 | (iii) It also means an individual residing outside of this state, covered by a group that |
12 | provides health benefits on a self-insurance basis, when such group has elected to participate in the |
13 | program, pursuant to rules established by the secretary. |
14 | (iv) "Contribution enrollee" shall not include an individual whose health care services are |
15 | paid or reimbursed by Part A or Part B of the Medicare program, a Medicare supplemental policy |
16 | as defined in section 1882 of the Social Security Act, 42 U.S.C. § 1395ss(a)(1) and 42 C.F.R. § |
17 | 403.205, or Medicare managed care policy, unless such federal program becomes eligible, as |
18 | determined by the secretary. |
19 | (2) "Council" means the rare diseases advisory council. |
20 | (3) "Covered drug" means a high cost prescription drug, gene therapy, or cell therapy |
21 | designated as an orphan drug by the Federal Drug Administration and determined by the secretary |
22 | as a reinsurance eligible drug under the program. The secretary's designation of a drug as a covered |
23 | drug shall be made with the input of an advisory council. |
24 | (4) "Executive office" means the executive office of health and human services. |
25 | (5) "Fund" means the rare disease medication reinsurance fund established by § 23-97-3. |
26 | (6)(i) "Insurer" means all persons offering, administering, and/or insuring health care |
27 | services, including, but not limited to: |
28 | (A) Policies of accident and sickness insurance, as defined by chapter 18 of title 27: |
29 | (B) Nonprofit hospital or medical-service plans, as defined by chapters 19 and 20 of title |
30 | 27; |
31 | (C) Any person whose primary function is to provide diagnostic, therapeutic, or preventive |
32 | services to a defined population on the basis of a periodic premium; |
33 | (D) All domestic, foreign, or alien insurance companies, mutual associations, and |
34 | organizations; |
| LC003915 - Page 2 of 15 |
1 | (E) Health maintenance organizations, as defined by chapter 41 of title 27; |
2 | (F) All persons providing health benefits coverage on a self-insurance basis; |
3 | (G) All third-party administrators described in chapter 20.7 of title 27; and |
4 | (H) All persons providing chapter 20.2 of title 27 health benefit coverage under Title XIX |
5 | of the Social Security Act (Medicaid) as a Medicaid managed care organization offering managed |
6 | Medicaid. |
7 | (ii) "Insurer" shall not include any nonprofit dental service corporation as defined in § 27- |
8 | 20.1-1, nor any insurer offering only those coverages described in §§ 23-97-16 and 42-7.4-13. |
9 | (7) "Person" means any individual, corporation, company, association, partnership, limited |
10 | liability company, firm, state governmental corporations, districts, and agencies, joint stock |
11 | associations, trusts, and the legal successor thereof. |
12 | (8) "Rare disease medication funding contribution" means per capita amount each |
13 | contributing insurer must contribute to support the program funded by the method established under |
14 | this chapter, with respect to each contribution enrollee. |
15 | (9) "Secretary" means the secretary of the executive office of health and human services |
16 | (EOHHS). |
17 | 23-97-3. Establishment of program fund. |
18 | (a) The rare disease medication reinsurance fund is hereby established to provide funding |
19 | for the operation and administration of the program carrying out the purposes of this chapter. A |
20 | restricted-receipt account shall be established for the fund which may be used for the purposes set |
21 | forth in this section and shall be exempt from the indirect cost recovery provisions of § 35-4-27. |
22 | The general treasurer is authorized and directed to draw his or her orders on the account upon |
23 | receipt of properly authenticated vouchers from the secretary. |
24 | (b) The secretary is authorized to administer the fund. |
25 | (c) The fund shall consist of monies collected pursuant to this chapter. In addition, the |
26 | secretary may seek or receive, and the general treasurer is authorized to accept, any grant, devise, |
27 | bequest, donation, gift, or assignment of money, bonds, or securities; funds from any state or federal |
28 | agency; and settlements. The funds shall be deposited into the restricted receipt account established |
29 | for the fund and used solely for the purposes of the "rare diseases medication reinsurance fund", |
30 | and no other. |
31 | (d) No general revenue funding shall be used for reinsurance payments. |
32 | (e) The secretary shall submit to the general assembly an annual report on the program and |
33 | costs related to the program, on or before February 1 of each year. The executive office shall make |
34 | the report available to each insurer required to make a contribution pursuant to this chapter. |
| LC003915 - Page 3 of 15 |
1 | 23-97-4. Establishment of rare diseases advisory council. |
2 | (a) Creation of an advisory council. There is hereby created and established a funding for |
3 | rare diseases medication advisory council, to be referred to in this chapter as "the council." |
4 | (1) The council shall be composed of fifteen (15) members, each to be selected by the |
5 | secretary unless otherwise noted, as follows: |
6 | (i) The directors of the following four (4) offices in state government, or their designees: |
7 | the department of health, the department of administration, the department of human services |
8 | Medicaid program, and the office of the health insurance commissioner; |
9 | (ii) One representative of the University of Rhode Island, School of Pharmacy with |
10 | expertise in the study of clinical effectiveness, to be appointed by the dean of the school; |
11 | (iii) Three (3) representatives of insurers, one of whom shall be a Medicaid managed care |
12 | organization; |
13 | (iv) One representative of a pharmacy benefit manager, to be selected by the secretary; |
14 | (v) Three (3) representatives of prescribers, representing different clinical specialties, |
15 | knowledgeable about the treatment of rare diseases, and at least one of whom shall be a licensed |
16 | pediatrician; |
17 | (vi) One representative of the Rhode Island Patient Information Network or if such |
18 | organization ceases to exist then another local representative from another patient advocacy |
19 | organization. |
20 | (vii) One representative of an organization that self-funds its health coverage. |
21 | (viii) One representative of a municipality or municipal purchasing collaborative. |
22 | (2) Council members must be independent and free of conflict of interest with respect to |
23 | any pharmaceutical manufacturer or distributor that might be interested in the decision to include |
24 | a medication as a covered drug. The secretary shall protect against such conflict of interest by |
25 | requiring disclosures and preclude a person's service on the council based on economic or other |
26 | interests, including employment or appointments, financial interests, payments, funding, gifts, or |
27 | other relationships that would compromise a council member's independence. |
28 | (3) The secretary may solicit input from other organizations or experts the secretary |
29 | determines are essential for the proper execution of the program. |
30 | (4) Should any member cease to be an officer or employee of the entity he or she is |
31 | appointed to represent, his or her membership shall terminate immediately. Any vacancy shall be |
32 | filled by the appointing authority in the same manner as the original appointment. |
33 | (5) The members of the council shall elect a chairperson and vice chairperson by a majority |
34 | vote of those present and voting. |
| LC003915 - Page 4 of 15 |
1 | (6) The secretary shall make the appointments to the council as described in this subsection |
2 | and call the first meeting of the council within four (4) months of the effective date of this chapter. |
3 | (b) Duties of the advisory council. Based on information from the secretary, the council |
4 | shall recommend the drugs to be covered, an assessment rate, and a funding distribution method. |
5 | (1) The council shall recommend for inclusion only those medications that are high cost |
6 | prescription drugs, gene therapies or cell therapies designated as orphan drugs by the Federal Drug |
7 | Administration. The council shall review and recommend for inclusion those medications with the |
8 | greatest medical efficacy and which treat those conditions expected to occur with the lowest |
9 | frequency, and may consider any other factor or factors the council determines to be relevant, in |
10 | making a recommendation to the secretary that a medication be a covered drug eligible for |
11 | reimbursement under the program. |
12 | (2) The secretary shall inform the council of the price of each prospective medication and |
13 | the estimated number of treatable cases based on the treatment frequency for each drug and the |
14 | population eligible for coverage under the program. |
15 | (3) The council shall recommend a preliminary funding contribution for each |
16 | recommended drug in an amount equal to: the price for each drug multiplied by the estimated |
17 | number of treatable cases, divided by the number of contribution enrollees. An additional amount |
18 | shall be included to improve the likelihood that sufficient funds will be available and for the |
19 | expense of the secretary for administering the program, by adding an amount not to exceed four |
20 | percent (4%) of the preliminary funding contribution for each covered drug. No additional costs |
21 | shall be added to the contribution rate. |
22 | (4) The council shall review and advise the secretary on the process for distributing |
23 | reinsurance funds. |
24 | 23-97-5. Rare disease medication pricing. |
25 | (a) The secretary is hereby authorized and directed to create a drug pricing plan for covered |
26 | drugs. Manufacturers and distributors of the covered drugs shall offer and accept such prices and |
27 | terms from participating insurers. In developing the pricing plan, the secretary shall: |
28 | (1) Utilize and base the price of a covered drug on the current medical assistance |
29 | (Medicaid) drug program price or may negotiate state-specific prices or participate in multi-state |
30 | pooling or other collaborative programs, either of which may include rebates, discounts, or other |
31 | agreements with pharmaceutical companies. |
32 | (2) Utilize alternative payment methods including, but not limited to, value-based |
33 | payments or performance guarantees, or which distribute the financial burden over time by |
34 | amortizing the costs. |
| LC003915 - Page 5 of 15 |
1 | 23-97-6. Determination of covered drugs and funding contribution. |
2 | (a) Beginning February 1, 2023 and annually thereafter, the secretary shall announce the |
3 | covered drugs and set the rare disease medication funding contribution in the manner described in |
4 | this chapter. |
5 | (b) The secretary shall determine the covered drug or drugs and the contribution rate to |
6 | generate program funds, based on the recommendations of the council. The secretary may |
7 | determine not to include a drug recommended by the council. To determine the final funding |
8 | contribution rate, the secretary shall add the individual contribution rates for each drug the secretary |
9 | determines shall be a covered drug under the program. |
10 | (c) Each insurer is required to pay the rare disease medication funding contribution for each |
11 | contribution enrollee of the insurer at the time the contribution is calculated and paid, at the rate set |
12 | forth in this section. |
13 | (1) The contribution set forth in this section shall be in addition to any other fees or |
14 | assessments upon the insurer allowable by law. |
15 | (d) The contribution shall be paid by the insurer; provided, however, a person providing |
16 | health benefits coverage on a self-insurance basis that uses the services of a third-party |
17 | administrator shall not be required to make a contribution for a contribution enrollee where the |
18 | contribution on that enrollee has been or will be made by the third-party administrator. |
19 | (e) A person providing health benefits coverage on a self-insurance basis shall inform the |
20 | secretary of the intent to participate in the program for the individuals covered by the plan residing |
21 | outside of this state, pursuant to rules established by the secretary. An affirmative election must be |
22 | in place and contributions made for these out-of-state enrollees at least one year prior to a claim |
23 | being submitted for such out of state enrollees. |
24 | 23-97-7. Returns and payment. |
25 | (a) Beginning in April of 2024, and subject to subsection (b) of this section, every insurer |
26 | required to make a contribution shall, on or before the last day of January, April, July, and October |
27 | of each year, make a return to the secretary together with payment of the quarterly funding |
28 | contribution for the preceding three (3) month period. |
29 | (b) Any insurer required to make the contribution that can substantiate that the insurer's |
30 | contribution liability would average less than twenty-five thousand dollars ($25,000) per month |
31 | may file returns and remit payment annually on or before the last day of January each year |
32 | (beginning January of 2025); provided, however, that the insurer shall be required to make quarterly |
33 | payments if the secretary determines that: |
34 | (1) The insurer has become delinquent in either the filing of the return or the payment of |
| LC003915 - Page 6 of 15 |
1 | the funding contribution due; or |
2 | (2) The liability of the insurer exceeds seventy-five thousand dollars ($75,000) in funding |
3 | contributions per quarter for any two (2) subsequent quarters. |
4 | (c) All returns shall be signed by the insurer required to make the contribution, or by its |
5 | authorized representative, subject to the pains and penalties of perjury. |
6 | (d) If a return shows an overpayment of the contribution due, the secretary shall refund or |
7 | credit the overpayment to the insurer required to make the contribution, or the insurer may deduct |
8 | the overpayment from the next quarterly or annual return. |
9 | (e) The secretary, for good cause shown, may extend the time within which an insurer is |
10 | required to file a return, and if the return is filed during the period of extension, no penalty or late |
11 | filing charge may be imposed for failure to file the return at the time required by this section; |
12 | however, the insurer shall be liable for interest as prescribed in this section. Failure to file the return |
13 | during the period for the extension shall void the extension. |
14 | 23-97-8. Set-off for delinquent payment. |
15 | If an insurer required to make the contribution pursuant to this chapter shall fail to pay a |
16 | contribution within thirty (30) days of its due date, the secretary may request any agency of state |
17 | government making payments to the insurer to set-off the amount of the delinquency against any |
18 | payment or amount due the insurer from the agency of state government and remit the sum to the |
19 | secretary. Upon receipt of the setoff request from the secretary, any agency of state government is |
20 | authorized and empowered to set-off the amount of the delinquency against any payment or |
21 | amounts due the insurer. The amount of set-off shall be credited against the contribution due from |
22 | the insurer. |
23 | 23-97-9. Assessment on available information – Interest on delinquencies – Penalties |
24 | – Collection powers. |
25 | If any insurer shall fail to file a return within the time required by this chapter, or shall file |
26 | an insufficient or incorrect return, or shall not pay the contribution imposed by this chapter when |
27 | it is due, the secretary shall assess the contribution upon the information as may be available, which |
28 | shall be payable upon demand and shall bear interest at the annual rate provided by § 44-1-7, from |
29 | the date when the contribution should have been paid. If the failure is due, in whole or part, to |
30 | negligence or intentional disregard of the provisions of this chapter, a penalty of ten percent (10%) |
31 | of the amount of the determination shall be added to the contribution. The secretary shall collect |
32 | the contribution with interest. The secretary may request any agency to assist in collection, |
33 | including the tax administrator, who may collect the contribution with interest in the same manner |
34 | and with the same powers as are prescribed for collection of taxes in title 44. |
| LC003915 - Page 7 of 15 |
1 | 23-97-10. Claims for refund or payment – Hearing upon denial. |
2 | (a) Any insurer required to pay the contribution or making a request for reinsurance |
3 | payment may file a claim for refund or payment with the secretary at any time within one year after |
4 | the contribution has been paid or reinsurance payment request made. If the secretary shall determine |
5 | that the contribution has been overpaid, or that a payment to the insurer was due or underpaid, he |
6 | or she shall make a refund or payment with ten percent (10%) interest from the date of overpayment, |
7 | or the date the payment was due. |
8 | (b) Any insurer whose claim for refund or reinsurance payment has been denied may, |
9 | within thirty (30) days from the date of the mailing by the secretary of the notice of the decision, |
10 | request a hearing and the secretary shall, as soon as practicable, set a time and place for the hearing |
11 | and shall notify the insurer. |
12 | 23-97-11. Hearing by secretary on application. |
13 | Any insurer aggrieved by the action of the secretary in determining the amount of any |
14 | contribution, reinsurance payment, or penalty imposed under the provisions of this chapter may |
15 | apply to the secretary, within thirty (30) days after the notice of the action is mailed to it, for a |
16 | hearing relative to the contribution, payment, or penalty. The secretary shall fix a time and place |
17 | for the hearing and shall so notify the insurer. After hearing, the secretary shall correct manifest |
18 | errors, if any, disclosed at the hearing and thereupon assess and collect, or pay, the amount lawfully |
19 | due together with any penalty or interest thereon. |
20 | 23-97-12. Appeals. |
21 | Appeals from administrative orders or decisions made pursuant to any provisions of this |
22 | chapter shall be pursued pursuant to chapter 35 of title 42. The right to appeal under this section |
23 | shall be expressly made conditional upon prepayment of all contribution, interest, and penalties or |
24 | the posting of a bond with surety in lieu of payment or other appropriate security. If the court, after |
25 | appeal, holds that the insurer is entitled to a refund or payment, the insurer shall also be paid interest |
26 | on the amount at the rate provided in § 44-1-7.1. If the insurer has satisfied the conditions for appeal |
27 | by posting a bond and prevails on appeal, the court shall order the surrender or cancellation of the |
28 | bond. |
29 | 23-97-13. Records. |
30 | Every insurer required to make the contribution shall: |
31 | (1) Keep records as may be necessary to determine the amount of its liability or claim for |
32 | reinsurance payment under this chapter; |
33 | (2) Preserve those records for a period of three (3) years following the date of filing of any |
34 | return or claim required by this chapter, or until any litigation or prosecution under this chapter is |
| LC003915 - Page 8 of 15 |
1 | finally determined; and |
2 | (3) Make those records available for inspection by the secretary or his/her authorized |
3 | agents, upon demand, at reasonable times during regular business hours. |
4 | 23-97-14. Method of payment and deposit of contribution. |
5 | (a) The payments required by this chapter may be made by electronic transfer of monies to |
6 | the general treasurer. |
7 | (b) The general treasurer shall take all steps necessary to facilitate the transfer of monies |
8 | to the rare disease medication funding account described in § 23-97-3. |
9 | (c) Any remainder in the account after funds have been distributed in a program year shall |
10 | be retained for use in subsequent program years. |
11 | (d) The general treasurer shall provide the secretary with a record of any monies transferred |
12 | and deposited. |
13 | 23-97-15. Rules and regulations. |
14 | The secretary is authorized to make and promulgate rules, regulations, and procedures not |
15 | inconsistent with state law and fiscal procedures as he or she deems necessary for the proper |
16 | administration of this chapter and to carry out the provisions, policies, and purposes of this chapter |
17 | including, but not limited to, data it must collect from insurers for the correct computation of the |
18 | funding contribution, collaboration with other state agencies for collecting necessary information, |
19 | and the form of the return and the data that it must contain for the correct computation of the funding |
20 | contribution. |
21 | 23-97-16. Excluded coverage from the health care services funding plan act. |
22 | (a) In addition to any exclusion and exemption contained elsewhere in this chapter, this |
23 | chapter shall not apply to insurance coverage providing benefits for, nor shall an individual be |
24 | deemed a contribution enrollee solely by virtue of receiving benefits for the following: |
25 | (1) Hospital confinement indemnity; |
26 | (2) Disability income; |
27 | (3) Accident only; |
28 | (4) Long-term care; |
29 | (5) Medicare supplement; |
30 | (6) Limited benefit health; |
31 | (7) Specified disease indemnity; |
32 | (8) Sickness or bodily injury or death by accident or both; and |
33 | (9) Other limited benefit policies. |
34 | 23-97-17. Impact on health insurance rates. |
| LC003915 - Page 9 of 15 |
1 | (a) Allocation. An insurer required to make a funding contribution under this chapter may |
2 | pass on the cost of that contribution in the cost of its services, such as its premium rates (for |
3 | insurers), without being required to specifically allocate those costs to individuals or populations |
4 | that actually incurred the contribution. The costs are to be fairly allocated among the market |
5 | segments incurring such costs. |
6 | (b) Oversight. The health insurance commissioner shall ensure, through the rate review and |
7 | approval process, that the rates filed for fully insured groups and individuals, pursuant to chapters |
8 | 18.5, 18.6 or 50 of title 27, reflect the transition to the funding method described in this chapter. |
9 | 23-97-18. Distribution from the rare disease medication reinsurance fund. |
10 | (a) The secretary shall by regulation implement a state-based reinsurance program to |
11 | provide insurers with reinsurance payments for covered drugs. The program is intended to mitigate |
12 | the impact of high-cost prescription drugs and gene or cell therapies on the cost of health care |
13 | coverage offered by the insurer. |
14 | (1) Reinsurance payments shall be available for claims for covered drugs paid by an insurer |
15 | on or after January 1, 2024. |
16 | (2) An insurer becomes eligible for payment from the reinsurance fund when it pays for |
17 | one or more covered drugs in a calendar year. |
18 | (3) Insurers may request reinsurance payments on a calendar year basis. The secretary shall |
19 | establish a timely filing requirement for insurers to receive a reinsurance payment for a covered |
20 | drug. Such timely filing requirement shall not be less than one hundred eighty (180) days nor more |
21 | than twelve (12) months following the end of the calendar year. An insurer that does not submit a |
22 | request for reinsurance payment within the timely filing period shall not be eligible for reinsurance |
23 | payment |
24 | (4) The secretary will calculate the total reinsurance payment owed to each insurer within |
25 | ninety (90) days of the date all insurer requests for payment are due to the secretary. |
26 | (5) The secretary may establish such program elements as it deems appropriate to ensure |
27 | equitable distribution of the fund, including attachment points, coinsurance rates, and/or |
28 | coinsurance caps which may be applied in aggregate or per covered drug. Such program elements |
29 | may be adjusted no more frequently than annually with the input of the rare diseases advisory |
30 | council. |
31 | (6) In no event shall the reinsurance payment to an insurer exceed the total amount paid by |
32 | the insurer for a covered drug after rebates. |
33 | (b) Insurers must provide the secretary with data prescribed by the secretary in rules and |
34 | regulations as necessary in order to substantiate a claim for reinsurance payment from the fund in |
| LC003915 - Page 10 of 15 |
1 | a time and manner determined by the secretary. |
2 | (c) Any balance remaining in the fund after such reinsurance payments shall be applied to |
3 | claims in subsequent years as described in this chapter. In no event shall all reinsurance payments |
4 | in a calendar year to all insurers exceed the amount collected pursuant to § 23-97-7 plus any funds |
5 | remaining from prior years. |
6 | SECTION 3. Section 35-4-27 of the General Laws in Chapter 35-4 entitled "State Funds" |
7 | is hereby amended to read as follows: |
8 | 35-4-27. Indirect cost recoveries on restricted receipt accounts. |
9 | Indirect cost recoveries of ten percent (10%) of cash receipts shall be transferred from all |
10 | restricted-receipt accounts, to be recorded as general revenues in the general fund. However, there |
11 | shall be no transfer from cash receipts with restrictions received exclusively: (1) From contributions |
12 | from nonprofit charitable organizations; (2) From the assessment of indirect cost-recovery rates on |
13 | federal grant funds; or (3) Through transfers from state agencies to the department of administration |
14 | for the payment of debt service. These indirect cost recoveries shall be applied to all accounts, |
15 | unless prohibited by federal law or regulation, court order, or court settlement. The following |
16 | restricted receipt accounts shall not be subject to the provisions of this section: |
17 | Executive Office of Health and Human Services |
18 | Rare Disease Medication Reinsurance Fund |
19 | Organ Transplant Fund |
20 | HIV Care Grant Drug Rebates |
21 | Health System Transformation Project |
22 | Department of Human Services |
23 | Veterans' home -- Restricted account |
24 | Veterans' home -- Resident benefits |
25 | Pharmaceutical Rebates Account |
26 | Demand Side Management Grants |
27 | Veteran's Cemetery Memorial Fund |
28 | Donations -- New Veterans' Home Construction |
29 | Department of Health |
30 | Pandemic medications and equipment account |
31 | Miscellaneous Donations/Grants from Non-Profits |
32 | State Loan Repayment Match |
33 | Healthcare Information Technology |
34 | Department of Behavioral Healthcare, Developmental Disabilities and Hospitals |
| LC003915 - Page 11 of 15 |
1 | Eleanor Slater non-Medicaid third-party payor account |
2 | Hospital Medicare Part D Receipts |
3 | RICLAS Group Home Operations |
4 | Commission on the Deaf and Hard of Hearing |
5 | Emergency and public communication access account |
6 | Department of Environmental Management |
7 | National heritage revolving fund |
8 | Environmental response fund II |
9 | Underground storage tanks registration fees |
10 | De Coppet Estate Fund |
11 | Rhode Island Historical Preservation and Heritage Commission |
12 | Historic preservation revolving loan fund |
13 | Historic Preservation loan fund -- Interest revenue |
14 | Department of Public Safety |
15 | E-911 Uniform Emergency Telephone System |
16 | Forfeited property -- Retained |
17 | Forfeitures -- Federal |
18 | Forfeited property -- Gambling |
19 | Donation -- Polygraph and Law Enforcement Training |
20 | Rhode Island State Firefighter's League Training Account |
21 | Fire Academy Training Fees Account |
22 | Attorney General |
23 | Forfeiture of property |
24 | Federal forfeitures |
25 | Attorney General multi-state account |
26 | Forfeited property -- Gambling |
27 | Department of Administration |
28 | OER Reconciliation Funding |
29 | Health Insurance Market Integrity Fund |
30 | RI Health Benefits Exchange |
31 | Information Technology Investment Fund |
32 | Restore and replacement -- Insurance coverage |
33 | Convention Center Authority rental payments |
34 | Investment Receipts -- TANS |
| LC003915 - Page 12 of 15 |
1 | OPEB System Restricted Receipt Account |
2 | Car Rental Tax/Surcharge-Warwick Share |
3 | Executive Office of Commerce |
4 | Housing Resources Commission Restricted Account |
5 | Department of Revenue |
6 | DMV Modernization Project |
7 | Jobs Tax Credit Redemption Fund |
8 | Legislature |
9 | Audit of federal assisted programs |
10 | Department of Children, Youth and Families |
11 | Children's Trust Accounts -- SSI |
12 | Military Staff |
13 | RI Military Family Relief Fund |
14 | RI National Guard Counterdrug Program |
15 | Treasury |
16 | Admin. Expenses -- State Retirement System |
17 | Retirement -- Treasury Investment Options |
18 | Defined Contribution -- Administration - RR |
19 | Violent Crimes Compensation -- Refunds |
20 | Treasury Research Fellowship |
21 | Business Regulation |
22 | Banking Division Reimbursement Account |
23 | Office of the Health Insurance Commissioner Reimbursement Account |
24 | Securities Division Reimbursement Account |
25 | Commercial Licensing and Racing and Athletics Division Reimbursement Account |
26 | Insurance Division Reimbursement Account |
27 | Historic Preservation Tax Credit Account |
28 | Judiciary |
29 | Arbitration Fund Restricted Receipt Account |
30 | Third-Party Grants |
31 | RI Judiciary Technology Surcharge Account |
32 | Department of Elementary and Secondary Education |
33 | Statewide Student Transportation Services Account |
34 | School for the Deaf Fee-for-Service Account |
| LC003915 - Page 13 of 15 |
1 | School for the Deaf -- School Breakfast and Lunch Program |
2 | Davies Career and Technical School Local Education Aid Account |
3 | Davies -- National School Breakfast & Lunch Program |
4 | School Construction Services |
5 | Office of the Postsecondary Commissioner |
6 | Higher Education and Industry Center |
7 | Department of Labor and Training |
8 | Job Development Fund |
9 | SECTION 4. This act shall take effect upon passage. |
======== | |
LC003915 | |
======== | |
| LC003915 - Page 14 of 15 |
EXPLANATION | |
BY THE LEGISLATIVE COUNCIL | |
OF | |
A N A C T | |
RELATING TO HEALTH AND SAFETY -- THE RHODE ISLAND RARE DISEASE | |
MEDICATION ACCESSIBILITY, AFFORDABILITY AND REINSURANCE ACT | |
*** | |
1 | This act would establish within the executive office of health and human services (EOHHS) |
2 | a rare disease medication reinsurance program fund in consultation with an advisory council, to |
3 | assure equitable financing and facilitate access to medication for rare diseases. |
4 | This act would take effect upon passage. |
======== | |
LC003915 | |
======== | |
| LC003915 - Page 15 of 15 |